CD9 and cancer: Moreover, Miki et al. showed increased migration and invasion abilities in CD9-positive exosomes from cancer-associated fibroblasts of scirrhous-type gastric cancer cells, and the prognosis of patients with positive CD9 expression was worse than CD9-negative patients.